Background
==========

Patellofemoral pain syndrome (PFP), or idiopathic pain arising from the anterior knee, is one of the most common musculoskeletal conditions affecting young active adults \[[@B1]-[@B6]\], and has a tendency to persist to some degree in a substantial proportion of affected individuals \[[@B7]\]. Prospective longitudinal studies have demonstrated the propensity towards chronicity of PFP in active populations (adolescent females \[[@B8]\], military personnel \[[@B9]\]). Identification of people who are likely to have persistent PFP will enable clinicians to provide patients with a more accurate picture of their prognosis \[[@B10]\], thereby facilitating negotiation of more realistic expectations of outcome and long term management \[[@B11]\].

Prognostic factors, such as demographic, diagnostic or co-morbid characteristics of an individual measured at baseline, are generally used to identify those with a greater likelihood of a poor outcome over time \[[@B12],[@B13]\]. Several attempts have been made to determine prognostic indicators of outcome in PFP \[[@B14]-[@B17]\]; however, due to methodological issues it is difficult to draw valid conclusions applicable to the clinical context. For example, treatment was not accounted for in the design and analysis of any of these studies, thereby making it difficult to discern if it was the treatment or the derived prognostic factors that was responsible for the outcome. One study did not exclude volunteers with PFP of traumatic onset \[[@B14]\], while other studies utilised outcome measures not specific to PFP (e.g. Lysholm functional knee score \[[@B16],[@B17]\]) or the clinic (e.g. laboratory-based tests \[[@B14]\]). Notwithstanding these shortcomings, the individual studies identified older age, greater height, and longer duration of symptoms as some prognostic factors, but none of these variables were found consistently across multiple studies.

On the basis of this, further high-quality research into the predictive ability of variables such as age, gender, body mass index (BMI), foot posture, duration of symptoms, pain severity and functional limitation is warranted. A systematic review found older age, higher baseline pain severity, longer pain duration and higher baseline disability to be consistent prognostic factors in musculoskeletal conditions \[[@B11]\]. The well-documented higher prevalence of PFP in females raises the question as to whether gender also influences prognosis \[[@B1],[@B18]\]. Although a previous study failed to identify BMI as a significant prognostic factor \[[@B17]\], baseline data from a recent randomised clinical trial \[[@B19]\] revealed a trend towards the higher end of normal for healthy body weight. As BMI is modifiable through weight control, its identification as a prognostic factor would provide another intervention by which to improve the prognosis of PFP sufferers, and hence should be further investigated. Despite a postulated relationship between PFP and foot posture \[[@B20],[@B21]\], the role of foot posture as a prognostic indicator has not been well investigated. Only one of the four previous prognostic studies investigated foot posture \[[@B17]\] using a measure of ankle hyperpronation during a bilateral squat (none 0-3°; mild 4-6°; clear \> 6°). However, the reliability and validity of this measure was not reported. Considering the recent development of a reliable method of measuring the foot \[[@B22]\], the prognostic ability of foot posture in PFP should be investigated further.

The tendency for PFP to become persistent and problematic in some individuals has long term implications for participation in daily and work tasks as well as physical activity \[[@B7]\]. The current literature provides only preliminary data on which to determine the prognosis of sufferers of this condition. In order to address this shortfall, baseline measures of such variables as age, gender, BMI, foot posture, duration of symptoms, pain severity and functional limitation were evaluated for their influence on short and long term outcome. The objective of this study was to determine whether there are reliable factors with high clinical utility that are predictive of poor short term (six and 12 weeks) and longer term (52 weeks) outcome on clinical measures of pain and function in individuals with PFP.

Methods
=======

Study design
------------

A prospective follow-up study was conducted post-hoc using data from a previously reported single-blind, single centre, 12-month randomised clinical trial \[[@B19],[@B23]\]. 179 participants with PFP were randomly assigned to a six-week treatment program of multimodal physiotherapy consisting of patellofemoral joint mobilisation, patellar taping, quadriceps muscle retraining and education (n = 45), prefabricated foot orthoses (n = 46), flat shoe inserts (n = 44), or foot orthoses plus physiotherapy (n = 44). Ethical approval was granted by The University of Queensland\'s medical research ethics committee, and all participants provided written informed consent.

Participants
------------

Participants were recruited from the greater Brisbane, Gold Coast and Toowoomba regions of Queensland, Australia between May 2004 and May 2006 through paid advertisements in print media, radio and television media, noticeboards, and referrals from practitioners. Volunteers underwent a clinical examination (including interview and physical examination) by an experienced physiotherapist, and were included if they fulfilled the following criteria \[[@B24]\]: (i) age 18 to 40 years; (ii) insidious onset of anterior knee or retropatellar pain greater than six weeks duration and provoked by at least two of: prolonged sitting or kneeling, squatting, running, hopping, or stair walking; (iii) tenderness on patellar palpation, or pain with step down or double leg squat; and (iv) pain over the previous week of at least 30 millimetres on a 100 millimetre visual analogue scale (VAS). Exclusion criteria were concomitant injury or pain from the hip or lumbar spine or other knee structures; previous knee surgery; patellofemoral instability; knee joint effusion; any foot condition that precluded use of foot orthoses; allergy to strapping tape; physiotherapy or foot orthoses within the previous year; or use of anti-inflammatory medication. Baseline characteristics of the participants are presented in Table [1](#T1){ref-type="table"}.

###### 

Baseline participant characteristics for the study cohort (n = 179); values are mean (SD) unless otherwise stated.

  Characteristics                                
  ---------------------------------------------- -------------
  Age (years)                                    29.3 (5.8)
                                                 
  Number (%) of females                          100 (55.9)
                                                 
  Height (cm)                                    173 (9.5)
                                                 
  Weight (kg)                                    74.7 (18.6)
                                                 
  Body Mass Index (kg/m^2^)                      24.8 (5.1)
                                                 
  Physical activity\* (kcal/kg)                  41 (7.3)
                                                 
  Bilateral knee pain: Number (%)                102 (57)
                                                 
  Duration of knee pain (months): Median (IQR)   28 (12-84)
                                                 
  Usual pain\^                                   36.3 (16.6)
                                                 
  Worst pain\^                                   60.5 (15.9)
                                                 
  Kujala Patellofemoral Score^†^                 71.5 (9.8)
                                                 
  Functional index questionnaire^‡^              9.8 (2.1)

\* Physical activity over the previous week questionnaire, total energy expended per day.

\^ Pain measured on a 100 mm visual analogue scale; 0 mm = no pain, 100 mm = worst pain imaginable.

^†^0-100 points; 100 = no disability.

^‡^0-16 points; 16 = no disability.

Predictor factors and outcome assessment
----------------------------------------

A blinded assessor recorded potential prognostic indicators at baseline prior to randomisation. Nine factors were selected for investigation with respect to their prognostic ability. Participant characteristics included age, gender, BMI and weight bearing arch height, which was measured as the distance from the standing surface to the dorsal surface of the foot at a point halfway along the length of the foot \[[@B22]\]. PFP variables were represented by duration of knee pain and baseline scores of pain and function. Worst pain over the preceding week was rated on a 100 millimetre VAS, with the descriptors \'no pain\' at the zero millimetre mark and \'worst pain imaginable\' anchoring the 100 millimetre end \[[@B25]\]. The Kujala Patellofemoral Score (KPS) consists of 13 items with discrete categories related to limp, weight bearing, walking, stairs, squatting, running, jumping, prolonged sitting with flexed knees, pain, swelling, painful patellar movements, thigh muscle atrophy, and flexion deficiency \[[@B26]\]. Participants selected one response to each item that best described their knee condition, and individual items were summed to provide a final score where zero represented maximal disability and 100 represented no disability. The functional index questionnaire (FIQ) comprises eight questions regarding aggravating activities for PFP \[[@B27]\]. Participants rated their degree of difficulty performing each activity, with the sum of scores providing an overall score of disability ranging from zero (maximal disability) to 16 (no disability). Pain-free step down repetitions were performed on a 25 centimetre step in an order that continually loaded the nominated lower limb \[[@B24]\]. A metronome set at 96 beats per minute was used to standardise the rate of testing. The repetition number on which the first onset of pain occurred, or the first increase in pain for participants who had a constant background ache prior to testing, was recorded, up to a maximum of 25 repetitions.

The blinded assessor measured outcome at six, 12 and 52 weeks by way of worst pain VAS, KPS and FIQ, which have established reliability and validity in PFP \[[@B25],[@B27]-[@B30]\].

Statistical analysis
--------------------

Statistical analysis was carried out using SPSS software (Version 15.0). The first stage of the analysis used univariate linear regression to investigate associations between each single potential prognostic factor and each outcome measure at six, 12 and 52 weeks. The baseline value of the outcome measure and the treatment group that participants were randomly assigned to within the randomised clinical trial were included as covariates in each analysis. Interactions between treatment group and each potential prognostic factor were evaluated to determine whether there existed any differences in prognostic variables between groups. For these interaction analyses, the flat insert group served as the reference group. This was done on the basis that flat inserts served as a control arm of the randomised clinical trial, as was borne out by the results thereof. A significance level of *p*≤ 0.1 rather than the conventional level of *p*\< 0.05 was selected to ensure that the univariate analyses were sufficiently sensitive to identify potential prognostic factors for entry in the model. This is consistent with the work of others in prognostic studies of musculoskeletal conditions \[[@B10],[@B31]\].

For the second stage, all potential prognostic factors that showed significant associations on univariate analyses were entered into a stepwise multivariate linear regression with backward elimination (*p*≤ 0.10) in order to identify a group of factors that were independently associated with poor outcome on each outcome measure at six, 12 and 52 weeks. This was conducted firstly without interactions, and then with significant interactions retained in the model. For the final multivariate models, the significance was set at 0.01 to minimise the results being adversely influenced by the likelihood of increased risk of Type I error associated with multiple analyses. The strength of the predictive ability of identified factors was determined with unstandardised regression coefficients (β) and their 95% confidence intervals, while the predictive power of each final model was given by calculation of the percentage of explained variance (adjusted R^2^).

Results
=======

Prognostic indicators of outcome at six weeks
---------------------------------------------

Univariate linear regression revealed that duration of knee pain, baseline scores of worst pain, FIQ and KPS, and number of pain-free step down repetitions were significantly associated with six-week KPS (additional file [1](#S1){ref-type="supplementary-material"}: Table S1). Of these, longer duration of knee pain (β-0.04, 95% confidence interval -0.07 to -0.01, *p*= 0.004) and lower baseline KPS (0.48, 0.31 to 0.65, *p*\< 0.000) remained significantly associated with a lower six-week KPS in the multivariate model, which explained 40.1% of the total variance.

All potential prognostic indicators except BMI had significant univariate associations with six-week FIQ. Longer duration (-0.01, -0.02 to 0, *p*= 0.006) and lower baseline FIQ (0.56, 0.36 to 0.77, *p*\< 0.000) remained significantly associated with lower six-week FIQ on multivariate analysis, which explained 38.6% of the total variance.

Age, duration, and baseline measures of worst pain, FIQ, KPS and pain-free step downs had significant univariate associations with six-week worst pain. The multivariate analysis showed that higher worst pain at baseline retained a significant association with a higher six-week worst pain (0.42, 0.16 to 0.69, *p*= 0.002; R^2^= 23%).

Significant univariate interactions between treatment group and age for all three outcome measures, as well as between treatment group and arch height for FIQ, did not significantly alter the predictor factors on outcome when included in the multivariate models.

Prognostic indicators of outcome at 12 weeks
--------------------------------------------

Baseline worst pain, KPS and pain-free step downs had significant univariate associations with 12-week KPS (additional file [1](#S1){ref-type="supplementary-material"}: Table S2). On multivariate analysis, lower baseline KPS retained a significant association with lower 12-week KPS (0.45, 0.27 to 0.64, *p*\< 0.000). The interaction between treatment group and baseline FIQ was not significant in the final model, with its inclusion only increasing the percentage of explained total variance from 23.2% to 28%, with baseline KPS remaining a significant predictor (0.43, 0.18 to 0.68, *p*= 0.001).

Univariate analyses found duration and baseline scores for worst pain and KPS to be significantly associated with 12-week FIQ. In the multivariate model, which explained 22% of the total variance, lower baseline KPS remained significantly associated with lower FIQ at 12 weeks (0.12, 0.07 to 0.16, *p*\< 0.000). The inclusion in the model of significant univariate interactions between treatment group and baseline FIQ, as well as treatment group and pain-free step downs, increased the explained variance to 34.7%; however KPS was no longer a significant predictor (0.08, 0.01 to 0.14, *p*= 0.019), nor were there any other significant associations.

On univariate analyses, age, duration, baseline scores of worst pain, FIQ and KPS, and number of pain-free step downs were significantly associated with 12-week worst pain. Multivariate analysis revealed no prognostic indicators of 12-week worst pain with or without the inclusion of the treatment group by duration interaction, which was significant on univariate analysis.

Prognostic indicators of outcome at 52 weeks
--------------------------------------------

Duration as well as worst pain and KPS at baseline had significant univariate associations with 52-week KPS (additional file [1](#S1){ref-type="supplementary-material"}: Table S3). Longer duration (-0.07, -0.1 to -0.03, *p*\< 0.000) and lower baseline KPS (0.33, 0.13 to 0.53, *p*= 0.002) maintained this significant association in the multivariate model, which explained 29.5% of the total variance. When interactions between treatment group and duration as well as treatment group and FIQ were included, the association between KPS at baseline and 52 weeks remained significant (0.4, 0.17 to 0.63, *p*= 0.001), but the association between duration and 52-week KPS was not statistically significant (-0.11, -0.19 to -0.02, *p*= 0.013). The final model with interactions included explained 49.7% of the total variance.

Age, duration, baseline scores of worst pain, FIQ and KPS, and pain-free step downs were all significantly associated with 52-week FIQ on univariate analyses. Multivariate analysis revealed that long duration was significantly associated with low 52-week FIQ (-0.02, -0.03 to -0.01, *p*\< 0.000), with the final model explaining 26.6% of the total variance. This did not change with the inclusion of the treatment group by age interaction.

On univariate analyses, duration and baseline scores of worst pain and KPS had significant associations with 52-week worst pain; however were not significant in the multivariate model (adjusted R^2^= 5.4%).

Discussion
==========

Multivariate regression analyses revealed that the two most consistent predictors of poor outcome in individuals with PFP over a 12-month period were a long duration of knee pain and a low baseline KPS. At six weeks, long pain duration was predictive of poor outcome on two of the three outcome measures (KPS and FIQ), while baseline scores of each measure that indicated greater severity of the condition not surprisingly predicted poor outcome on their respective measures. KPS was also found to be the sole prognostic indicator at 12 weeks when outcome was measured with the same questionnaire and the FIQ. Long pain duration was also predictive of poor outcome at 52 weeks when measured on the KPS and FIQ, while low KPS at baseline was predictive of poor 52-week outcome on the KPS.

Findings of our study are consistent with those of Mallen et al \[[@B11]\], whose systematic review of generic musculoskeletal pain found that longer pain duration and higher baseline disability were consistent prognostic indicators in musculoskeletal conditions. However, unlike Mallen et al \[[@B11]\] we did not find age to be predictive of outcome in our PFP cohort. This may be due to the difference in age ranges between studies. While our cohort was restricted to 18 to 40 years of age, the majority of studies in their systematic review included a greater age range of participants; frequently aged from 18 to at least 65 years \[[@B11]\]. It is also plausible that age is a condition-specific prognostic factor.

This study also confirms previous findings with respect to factors that are not predictive of outcome in PFP. Based on findings of ours and previous studies \[[@B15]-[@B17]\], gender does not appear to be a prognostic factor for PFP. The lack of association that we found between BMI and outcome is consistent with findings in both PFP \[[@B17]\] and general knee complaints \[[@B32]\], and implies that modifying or controlling BMI in those with PFP is unlikely to change their prognosis. One consideration is that, despite the inclusion of some individuals with a high BMI, overall this PFP group was not classified as overweight (Table [1](#T1){ref-type="table"}). Hence, further studies may need to consider subgroup analysis based on BMI classification.

This study investigated the prognostic role of foot posture based on the long-hypothesised relationship between foot pronation, biomechanical function of the patellofemoral joint, and the genesis of PFP \[[@B20]\]. While this has been explored in a previous prognostic study \[[@B17]\], ours is the first to utilise a reliable measure \[[@B22]\]. A static measure of weight bearing arch height was selected as a representative measure of foot posture, on the basis that it is reliable and valid, well correlated with dynamic foot function, and is simple and efficient to obtain in a clinical setting \[[@B33],[@B34]\]. Our finding that foot posture was not predictive of outcome in PFP is consistent with previous studies that failed to identify any other lower limb biomechanical measures as prognostic factors \[[@B15]-[@B17]\], although further research to confirm this for biomechanical measures other than foot posture is warranted.

While this study has identified pain duration and KPS as prognostic indicators, there may be other factors of a physical or psychological nature that are stronger predictors of outcome for PFP. Our findings provide guidelines as to physical factors worthy of inclusion in and exclusion from future prognostic studies. Psychological prognostic factors identified for other chronic musculoskeletal conditions such as anxiety and depression \[[@B11]\], and coping strategies such as catastrophising \[[@B35]\], require investigation in a PFP cohort.

Given that persistent knee pain has been implicated as a precursor to osteoarthritis \[[@B36],[@B37]\], the findings of this study are of substantial individual and public health importance. Our results suggest that, in order to optimise prognosis of individuals with PFP, it is best to attempt to prevent chronicity and minimise the severity of the condition. This may be achieved through education regarding the importance of early intervention to minimise duration. Intervention should aim to improve scores on the KPS, worst pain VAS and FIQ as quickly as possible, utilising modalities such as foot orthoses and multimodal physiotherapy that have the best evidence for efficacy in PFP \[[@B19],[@B24]\], as well as advice to avoid pain-provoking activities while maintaining an otherwise physically active lifestyle. Future clinical trials should also investigate the ability of other pain-relieving modalities to reduce pain more rapidly, such as electrotherapy, transcutaneous electrical nerve stimulation, analgesics, anti-inflammatory medication and acupuncture. Furthermore, KPS, worst pain VAS and FIQ scores that constitute low versus high severity need to be determined to facilitate more precise clinical application.

The inclusion of significant interactions between treatment group and potential prognostic variables in the multivariate model largely did not affect conclusions drawn from the final model, although there was generally an increase in the percentage of total variability explained by the model. This indicates that the prognostic factors identified for the entire cohort were not modified by any of the interventions.

Compared to previous prognostic studies, our study sought to control a number of factors that could compromise the external validity of its findings. Firstly, we have attempted to control for possible differential treatment effects and analyse outcome independent of intervention received. Because the previous four studies assigned the same standardised treatment program to all participants, their results look at the predictive ability of particular variables when treated with a standardised program \[[@B14]-[@B17]\]. In contrast, participants in the current study were randomly assigned to one of four different interventions, and treatment effects were accounted for in analyses through inclusion of treatment as a covariate. Secondly, we utilised outcome measures that have been previously established as reliable and valid for PFP. Thirdly, our methodology addresses a shortfall of previous musculoskeletal prognostic studies identified by Mallen et al \[[@B11]\], in that the measures investigated for potential predictive ability and those used to measure outcome have high clinical utility and are easily applied in a clinical setting.

Conclusions
===========

This study has identified simple, clinically appropriate and reliable condition-specific measures that are predictive of poor outcome in individuals with PFP. Patients presenting with PFP of long duration and a low KPS should be flagged as potentially having a poorer outcome over time, irrespective of their age, gender and morphometry. These findings suggest that attempting to prevent PFP chronicity by using efficacious interventions early after the onset of symptoms may optimise prognosis for this patient group, which may have important implications for prevention of potential sequelae of long term pain and disability.
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